Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.81M Sell
241,469
-55,895
-19% -$1.46M 0.23% 85
2026
Q1
$8.35M Sell
297,364
-13,406
-4% -$357K 0.39% 49
2025
Q4
$7.74M Buy
310,770
+30,212
+11% +$762K 0.36% 52
2025
Q3
$7.15M Buy
280,558
+30,084
+12% +$743K 0.37% 53
2025
Q2
$6.07M Buy
250,474
+14,016
+6% +$327K 0.36% 52
2025
Q1
$5.99M Buy
236,458
+30,040
+15% +$786K 0.38% 47
2024
Q4
$5.48M Buy
206,418
+5,157
+3% +$140K 0.34% 57
2024
Q3
$5.82M Buy
201,261
+9,121
+5% +$266K 0.38% 48
2024
Q2
$5.38M Buy
192,140
+5,210
+3% +$143K 0.38% 48
2024
Q1
$5.19M Buy
186,930
+130,779
+233% +$3.63M 0.31% 64
2023
Q4
$1.62M Sell
56,151
-7,244
-11% -$219K 0.3% 70
2023
Q3
$2.1M Buy
63,395
+6,365
+11% +$225K 0.39% 46
2023
Q2
$2.09M Buy
57,030
+1,403
+3% +$54.6K 0.37% 56
2023
Q1
$2.27M Buy
+55,627
New +$2.4M 0.46% 43

Other funds holding PFE

PFG Investments's PFE Position: Q2 2026 in Review

PFG Investments reduced its Pfizer (PFE) stake by 19% in Q2 2026, selling an estimated $1.46M and leaving 241,469 shares worth $5.81M. The position accounts for 0.23% of the portfolio, ranked #85.

PFG Investments first reported a position in PFE in Q1 2023 and has held it in 14 quarters since. The position peaked at $8.35M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • PFG Investments held 241,469 shares of Pfizer worth $5.81M as of Q2 2026.
  • PFG Investments sold 55,895 Pfizer shares in Q2 2026, an estimated $1.46M.
  • Pfizer made up 0.23% of PFG Investments's portfolio in Q2 2026, its #85 holding.
  • PFG Investments first reported a position in Pfizer in Q1 2023 and has held it in 14 quarters since.
  • PFG Investments's Pfizer position peaked at $8.35M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.